Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety
- 1. Hopital Beaujon, Clichy (France)
Description
Incubation of rat liver microsomes with [3H]methoxsalen and NADPH resulted in the covalent binding of a methoxsalen intermediate to proteins comigrating with cytochromes P-450 UT-A, PB-B/D, ISF-G and PCN-E. Binding was increased by pretreatments with phenobarbital, beta-naphthoflavone (beta NF) and dexamethasone. Such pretreatments also increased the loss of CO-binding capacity either after administration of methoxsalen, or after incubation of hepatic microsomes with methoxsalen and NADPH. Immunoprecipitation of the methoxsalen metabolite-protein adducts in phenobarbital-induced microsomes was moderate with anti-UT-A antibodies, but marked with anti-PB-B/D and anti-PCN-E antibodies. Immunoprecipitation was observed also with anti-ISF-G (anti-beta NF-B) antibodies in beta NF-induced microsomes. Methoxsalen (0.25 mM) inhibited markedly the benzphetamine demethylase activity of phenobarbital-induced microsomes and the erythromycin demethylase activity of dexamethasone-induced microsomes. Whereas methoxsalen itself did not produce any binding spectrum, in contrast either in vivo administration of methoxsalen or incubation in vitro with methoxsalen and NADPH resulted in a low-to-high spin conversion of cytochrome P-450 as suggested by the appearance of a spectrum analogous to a type I binding spectrum. This low-to-high spin conversion was apparently due to a methoxsalen intermediate (probably, covalently bound to the protein and preventing partial sixth ligation of the iron). We conclude that suicide inactivation of cytochrome P-450 by methoxsalen is related to the covalent binding of a methoxsalen intermediate to the protein moiety of several cytochrome P-450 isoenzymes (including UT-A, PB-B/D, PCN-E as well as ISF-G and/or beta NF-B)
Additional details
Publishing Information
- Journal Title
- Journal of Pharmacology and Experimental Therapeutics
- Journal Volume
- 250
- Journal Issue
- 3
- Series
- J. Pharmacol. Exp. Ther.
- Journal Page Range
- 1034-1042
- ISSN
- 0022-3565
- CODEN
- JPETA
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 21019101
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- BIOCHEMICAL REACTION KINETICS; CYTOCHROMES; DEXAMETHASONE; ENZYME ACTIVITY; FLAVONES; HEME; IMMUNOASSAY; INHIBITION; LIVER; MICROSOMES; NADP; OXIDOREDUCTASES; PHENOBARBITAL; PSORALEN; RATS; TRACER TECHNIQUES; TRITIUM COMPOUNDS
- Descriptors DEC
- ADRENAL HORMONES; ANESTHETICS; ANIMALS; ANTICOAGULANTS; ANTICONVULSANTS; AZINES; BARBITURATES; BODY; CARBOXYLIC ACIDS; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DEPRESS; COENZYMES; CORTICOSTEROIDS; DIGESTIVE SYSTEM; DRUGS; ENZYMES; FLAVENOIDS; GLANDS; GLUCOCORTICOIDS; HEMATOLOGIC AGENTS; HETEROCYCLIC ACIDS; HETEROCYCLIC COMPOUNDS; HORMONES; HYDROGEN COMPOUNDS; HYDROXY COMPOUNDS; HYPNOTICS AND SEDATIVES; ISOTOPE APPLICATIONS; KETONES; KINETICS; MAMMALS; NUCLEOTIDES; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; ORGANS; PIGMENTS; PORPHYRINS; PREGNANES; PYRIMIDINES; REACTION KINETICS; RODENTS; STEROID HORMONES; STEROIDS; VERTEBRATES